000148295 001__ 148295
000148295 005__ 20240229123030.0
000148295 0247_ $$2doi$$a10.1016/j.ctrv.2019.101933
000148295 0247_ $$2pmid$$apmid:31785412
000148295 0247_ $$2ISSN$$a0305-7372
000148295 0247_ $$2ISSN$$a1532-1967
000148295 0247_ $$2altmetric$$aaltmetric:72301390
000148295 037__ $$aDKFZ-2019-02859
000148295 041__ $$aeng
000148295 082__ $$a610
000148295 1001_ $$0P:(DE-HGF)0$$ad'Errico, Margherita$$b0$$eFirst author
000148295 245__ $$aIdentification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies.
000148295 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2020
000148295 3367_ $$2DRIVER$$aarticle
000148295 3367_ $$2DataCite$$aOutput Types/Journal article
000148295 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601365711_28271$$xReview Article
000148295 3367_ $$2BibTeX$$aARTICLE
000148295 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148295 3367_ $$00$$2EndNote$$aJournal Article
000148295 500__ $$a2020 Jan;82:101933#EA:C070#LA:C070#
000148295 520__ $$aThis systematic review aims to summarize epigenome-wide studies on aberrant DNA methylation and its association with survival in patients with gastrointestinal adenocarcinoma. The 15 studies identified showed a large variety of methodological approaches for the identification of prognostic epigenetic markers from genome-wide methylation analyses. None of the findings were reported by more than one study in this systematic review. Further validation studies, a better reporting of methods and results are needed, as well as a clearer definition of investigated outcomes. At present, no conclusions can be drawn on the clinical relevance of the reported epigenetic markers.
000148295 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000148295 588__ $$aDataset connected to CrossRef, PubMed,
000148295 7001_ $$0P:(DE-He78)9b2a61b2abe4a64ca23b6783b7c4fe63$$aAlwers, Elizabeth$$b1$$udkfz
000148295 7001_ $$0P:(DE-He78)d19149dd97b17ce55e70abd2f9e64d3d$$aZhang, Yan$$b2
000148295 7001_ $$0P:(DE-He78)92820b4867c955a04f642707ecf35b40$$aEdelmann, Dominic$$b3$$udkfz
000148295 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b4$$udkfz
000148295 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b5$$eLast author$$udkfz
000148295 773__ $$0PERI:(DE-600)2002084-3$$a10.1016/j.ctrv.2019.101933$$gVol. 82, p. 101933 -$$p101933$$tCancer treatment reviews$$v82$$x0305-7372$$y2020
000148295 909CO $$ooai:inrepo02.dkfz.de:148295$$pVDB
000148295 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000148295 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9b2a61b2abe4a64ca23b6783b7c4fe63$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000148295 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d19149dd97b17ce55e70abd2f9e64d3d$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000148295 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)92820b4867c955a04f642707ecf35b40$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000148295 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000148295 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000148295 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000148295 9141_ $$y2020
000148295 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000148295 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER TREAT REV : 2017
000148295 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148295 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148295 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148295 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148295 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000148295 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148295 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148295 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000148295 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000148295 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings
000148295 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER TREAT REV : 2017
000148295 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000148295 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000148295 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000148295 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000148295 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x2
000148295 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x3
000148295 980__ $$ajournal
000148295 980__ $$aVDB
000148295 980__ $$aI:(DE-He78)C070-20160331
000148295 980__ $$aI:(DE-He78)C060-20160331
000148295 980__ $$aI:(DE-He78)C120-20160331
000148295 980__ $$aI:(DE-He78)HD01-20160331
000148295 980__ $$aUNRESTRICTED